Evidence map›Paper›PMID 31939327›Full record

ReviewThe Journal of international medical research2020

Research progress in refractory sudden hearing loss: steroid therapy.

Ya Liu, Qiongqiong Chen, Yaping Xu

Abstract readReview
In one paragraph

Review in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. [Prospective randomised controlled observation of tympanic chamber injection of gangliosides in the treatment of refractory sudden deafness].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Trial
  2. Article
  3. Article
  4. A Selection Protocol to Identify Therapeutics to Target NLRP3-Associated Sensory Hearing Loss.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2024
    Article
  5. Article
  6. Article
  7. Promising Applications of Nanoparticles in the Treatment of Hearing Loss.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ya LiuDepartment of Otolaryngology - Head and Neck Surgery, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou City, Zhejiang Province, China.ORCID https://orcid.org/0000-0001-7386-4641
Qiongqiong ChenDepartment of Otolaryngology - Head and Neck Surgery, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou City, Zhejiang Province, China.
Yaping XuDepartment of Otolaryngology - Head and Neck Surgery, Zhejiang University School of Medicine First Affiliated Hospital, Hangzhou City, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DexamethasoneDrug Administration ScheduleDrug ResistanceGlucocorticoidsHearing Loss, SensorineuralHearing Loss, SuddenHumansMethylprednisoloneTreatment OutcomeDexamethasoneGlucocorticoidsMethylprednisoloneintratympanicpure-tone averageRefractory sudden sensorineural hearing lossresearch progresssalvage treatmentsteroid therapy

Identifiers

PMID31939327
PMCPMC7254608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.